CRISPR-Cas9 (Doudna-Charpentier 2012)

Layer 3 — Biologyin the biotechnology subtree

J Doudna-E Charpentier 2012 (Nobel 2020) CRISPR-Cas9 in-vitro; modern modern foundational + base / prime-editing 2017-2019 + 2023 FDA-Casgevy.

Related concepts